CVE-2019-12599
SuiteCRM 7.10.x before 7.10.17 and 7.11.x before 7.11.5 allows SQL Injection.
SuiteCRM 7.10.x before 7.10.17 and 7.11.x before 7.11.5 allows SQL Injection.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
SuiteCRM 7.10.x before 7.10.17 and 7.11.x before 7.11.5 allows SQL Injection.
- Record
CVE-2019-12599- CVSS 3.0
- 9.8 Critical
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - CVSS 2.0
- 7.5 High
AV:N/AC:L/Au:N/C:P/I:P/A:P - Weakness
- CWE-89
- Updated
- 2026-11-02
CVE List No score
SuiteCRM 7.10.x before 7.10.17 and 7.11.x before 7.11.5 allows SQL Injection.
- Record
CVE-2019-12599- Updated
- 2026-11-02
EUVDEUVD-2019-4193 No score
SuiteCRM 7.10.x before 7.10.17 and 7.11.x before 7.11.5 allows SQL Injection.
- Record
EUVD-2019-4193- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-4jwq-qx73-v7q4
SuiteCRM 7.10.x before 7.10.17 and 7.11.x before 7.11.5 allows SQL Injection.
SuiteCRM 7.10.x before 7.10.17 and 7.11.x before 7.11.5 allows SQL Injection.
- Record
GHSA-4jwq-qx73-v7q4- CVSS 3.0
- 9.8 Critical
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-89
- Updated
- 2026-11-02
OSV
SuiteCRM 7.10.x before 7.10.17 and 7.11.x before 7.11.5 allows SQL Injection.
- Record
CVE-2019-12599- CVSS 3.0
- 9.8 Critical
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD, OSV |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2019-12599 is a critical vulnerability (CVSS 9.8) in Salesagility Suitecrm, published June 7, 2019. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.06%, the 64th percentile. No source names a fixed version.